시장보고서

상품코드

1751228

두개 임플란트 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 재료별, 최종 용도별, 부문 예측(2025-2030년)

Cranial Implants Market Size, Share & Trends Analysis Report By Product (Customized, Non-Customized), By Material (Polymer, Ceramic, Metal), By End Use (Hospital, Neurosurgery Centers) and Segment Forecasts, 2025 - 2030

발행일: 2025년 05월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

두개 임플란트 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 두개 임플란트 시장 규모는 2030년까지 20억 9,000만 달러에 달할 것으로 예측됩니다.

2025-2030년 연평균 6.5%의 성장률을 보일 것으로 예측됩니다. 외상성 뇌손상(TBI)과 뇌종양 발병률 증가가 시장을 촉진할 것으로 예측됩니다.

두개골 임플란트 시장은 생체적합성과 기능성을 강화한 첨단 소재로 전환되고 있습니다. 폴리머와 금속이 여전히 주요 재료로 사용되고 있지만, 세라믹 임플란트는 우수한 심미적 결과와 천연 뼈와의 유사성으로 인해 선호도가 높아지고 있습니다.

3D 프린팅, 임플란트 제작을 위한 컴퓨터 보조 설계 및 제조(CAD/CAM), 더 큰 뼈 결손 부위의 재생을 위한 조직공학 치료 등의 기술 발전은 시장 확대의 주요 요인으로 작용하고 있습니다. 예를 들어 2024년 4월 3D Systems는 3D 프린팅 기술을 사용하여 제조된 환자 전용 VSP PEEK 두개골 임플란트에 대해 미국 식품의약국(FDA)의 510(k) 승인을 획득했습니다. 이번 승인은 표준 임상 진료에서 3D 프린팅의 채택 확대와 두개골 재건술에 큰 변화를 가져올 수 있는 잠재력을 강조하는 것입니다.

두개골 임플란트 시장 보고서 하이라이트

제품별로는 뇌종양 및 TBI로 인한 뇌손상 환자 증가로 인해 맞춤형 부문이 2024년 약 87%로 가장 큰 매출 점유율을 차지했습니다.
재료별로는 폴리머 부문이 2024년 주요 시장 점유율을 차지했습니다. 이는 두개골 결손 및 뇌종양 치료를 위한 두개골 성형술에서 폴리머의 사용량이 증가하고 있기 때문입니다.
병원은 숙련된 신경외과 의사의 가용성과 신흥 국가의 의료 인프라 개선으로 인해 2024년 두개골 임플란트 시장의 매출 점유율을 선도했습니다.
북미는 기술적으로 진보된 제품 채택, 정부의 구상, 높은 가처분 소득으로 인해 2024년 세계 시장에서 큰 점유율을 차지했습니다.
주요 기업은 경쟁 우위를 확보하기 위해 기술적으로 강화된 제품을 선택하고 있습니다. 2024년 8월, 메릴랜드에 본사를 둔 신경 기술 기업 Longeviti Neuro Solutions는 신경 외과수술에 적용하도록 설계된 혁신적인 반투명 인공 두개골 임플란트에 대한 미국 특허를 취득했습니다.

지역별 시장 대시보드
지역별 시장 점유율 분석, 2024년 및 2030년
지역별 시장 : 주요 포인트
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

주요 시장 참여 기업에 의한 최근 동향과 영향 분석
기업/경쟁 분류
벤더 구도
- Key Company Heat Map Analysis, 2024
기업 개요
- B. Braun SE
- Johnson &Johnson Services, Inc.
- Stryker
- Zimmer Biomet
- Acumed LLC
- evonos GmbH &Co. KG
- Medartis AG
- Renishaw plc.
- Kelyniam Global Inc.
- Anatomics Pty Ltd

KSA 25.06.26

Cranial Implants Market Growth & Trends:

The global cranial implants market size is anticipated to reach USD 2.09 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.5% from 2025 to 2030. Increasing cases of Traumatic Brain Injury (TBI) and brain tumors are anticipated to boost the market.

The cranial implants market is experiencing a shift toward advanced materials that offer enhanced biocompatibility and functionality. While polymers and metals remain the primary materials, ceramic implants are gaining traction due to their favorable aesthetic outcomes and similarity to natural bone.

Technological advancements, including 3D printing, Computer-aided Design and Manufacturing (CAD/CAM) for implant creation, and tissue engineering therapies aimed at regenerating larger bone defects, are significant drivers of market expansion. For instance, in April 2024, 3D Systems received Food and Drug Administration (FDA) 510(k) clearance for its patient-specific VSP PEEK Cranial Implant, which is manufactured using 3D printing technology. This regulatory clearance highlights the growing adoption of 3D printing in standard clinical practice and its potential to significantly transform cranial reconstruction procedures.

Cranial Implants Market Report Highlights:

By product, the customized segment held the largest revenue share approximately about 87% in 2024, attributed to the increasing number of patients suffering from brain defects due to brain tumors and TBIs
By material, polymer segment held a major market share in 2024, owing to increasing usage of polymer in cranioplasty surgical procedure for treatment of skull defects and brain tumor
Hospitals led the cranial implants market with a revenue share in 2024 due to the availability of skilled neurosurgeons and improving healthcare infrastructure in developing countries
North America dominated the global market with a major share in 2024, owing to the adoption of technologically advanced products, government initiatives, and high disposable income
Key players opt for technologically enhanced products to gain a competitive edge. In August 2024, Longeviti Neuro Solutions, a neurotechnology company headquartered in Maryland, was granted a U.S. patent for its innovative translucent prosthetic cranial implant designed for application in neurosurgical procedures.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Material
- 1.2.3. End use
- 1.2.4. Regional Scope
- 1.2.5. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
1.5. Information or Data Analysis
- 1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Material Outlook
- 2.2.3. End use Outlook
- 2.2.4. Regional Outlook
2.3. Competitive Insights

Chapter 3. Cranial Implants Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Cranial Implants Market Analysis tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrant
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political Landscape
  - 3.3.2.2. Technological Landscape
  - 3.3.2.3. Economic Landscape

Chapter 4. Cranial Implants Market: Product Estimates & Trend Analysis

4.1. Product Segment Dashboard
4.2. Cranial Implants Market: Product Movement Analysis
4.3. Global Cranial Implants Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Customized
- 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5. Non-Customized
- 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Cranial Implants Market: Material Estimates & Trend Analysis

5.1. Material Segment Dashboard
5.2. Cranial Implants Market: Material Movement Analysis
5.3. Global Cranial Implants Market Size & Trend Analysis, by Material, 2018 to 2030 (USD Million)
5.4. Polymer
- 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5. Ceramic
- 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6. Metal
- 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Cranial Implants Market: End Use Estimates & Trend Analysis

6.1. End Use Segment Dashboard
6.2. Cranial Implants Market: End Use Movement Analysis
6.3. Global Cranial Implants Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
6.4. Hospital
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5. Neurosurgery Centers
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Cranial Implants Market: Regional Estimates & Trend Analysis

7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Continuous Bioprocessing Market By Region: Key Takeaways
7.4. North America
- 7.4.1. U.S.
  - 7.4.1.1. Key Country Dynamics
  - 7.4.1.2. Regulatory Framework/ Reimbursement Structure
  - 7.4.1.3. Competitive Scenario
  - 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.2. Canada
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.4.2.3. Competitive Scenario
  - 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.3. Mexico
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Regulatory Framework/ Reimbursement Structure
  - 7.4.3.3. Competitive Scenario
  - 7.4.3.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5. Europe
- 7.5.1. UK
  - 7.5.1.1. Key Country Dynamics
  - 7.5.1.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.1.3. Competitive Scenario
  - 7.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.2. Germany
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.2.3. Competitive Scenario
  - 7.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.3. France
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.3.3. Competitive Scenario
  - 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.4. Italy
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.4.3. Competitive Scenario
  - 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.5. Spain
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.5.3. Competitive Scenario
  - 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.6. Denmark
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.6.3. Competitive Scenario
  - 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.7. Sweden
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.7.3. Competitive Scenario
  - 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.8. Norway
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.8.3. Competitive Scenario
  - 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Japan
  - 7.6.1.1. Key Country Dynamics
  - 7.6.1.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.1.3. Competitive Scenario
  - 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.2. China
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.2.3. Competitive Scenario
  - 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.3. India
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.3.3. Competitive Scenario
  - 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.4. Australia
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.4.3. Competitive Scenario
  - 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.5.3. Competitive Scenario
  - 7.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.6. Thailand
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.6.3. Competitive Scenario
  - 7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7. Latin America
- 7.7.1. Brazil
  - 7.7.1.1. Key Country Dynamics
  - 7.7.1.2. Regulatory Framework/ Reimbursement Structure
  - 7.7.1.3. Competitive Scenario
  - 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.2. Argentina
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.7.2.3. Competitive Scenario
  - 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8. MEA
- 7.8.1. South Africa
  - 7.8.1.1. Key Country Dynamics
  - 7.8.1.2. Regulatory Framework/ Reimbursement Structure
  - 7.8.1.3. Competitive Scenario
  - 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.8.2. Saudi Arabia
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.8.2.3. Competitive Scenario
  - 7.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.8.3. UAE
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Regulatory Framework/ Reimbursement Structure
  - 7.8.3.3. Competitive Scenario
  - 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.8.4. Kuwait
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. Regulatory Framework/ Reimbursement Structure
  - 7.8.4.3. Competitive Scenario
  - 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. Key Company Heat Map Analysis, 2024
8.4. Company Profiles
- 8.4.1. B. Braun SE
  - 8.4.1.1. Company Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. Johnson & Johnson Services, Inc.
  - 8.4.2.1. Company Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. Stryker
  - 8.4.3.1. Company Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. Zimmer Biomet
  - 8.4.4.1. Company Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Acumed LLC
  - 8.4.5.1. Company Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. evonos GmbH & Co. KG
  - 8.4.6.1. Company Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. Medartis AG
  - 8.4.7.1. Company Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. Renishaw plc.
  - 8.4.8.1. Company Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. Kelyniam Global Inc.
  - 8.4.9.1. Company Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. Anatomics Pty Ltd
  - 8.4.10.1. Company Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

두개 임플란트 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 재료별, 최종 용도별, 부문 예측(2025-2030년)

Cranial Implants Market Size, Share & Trends Analysis Report By Product (Customized, Non-Customized), By Material (Polymer, Ceramic, Metal), By End Use (Hospital, Neurosurgery Centers) and Segment Forecasts, 2025 - 2030

두개 임플란트 시장의 성장과 동향 :

두개골 임플란트 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 개요

제3장 두개 임플란트 시장의 변수, 동향, 범위

제4장 두개 임플란트 시장 : 제품별 추정·동향 분석

제5장 두개 임플란트 시장 : 재료별 추정·동향 분석

제6장 두개 임플란트 시장 : 최종 용도별 추정·동향 분석

제7장 두개 임플란트 시장 : 지역별 추정·동향 분석